BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
73.64
-1.12 (-1.50%)
At close: Dec 5, 2025, 4:00 PM EST
74.99
+1.35 (1.83%)
After-hours: Dec 5, 2025, 7:22 PM EST
BridgeBio Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 14,191 | 5,186 | 7,023 | 1,139 | 2,455 | 8,716 | |
| Market Cap Growth | 233.14% | -26.16% | 516.57% | -53.61% | -71.83% | 101.23% | |
| Enterprise Value | 15,405 | 6,661 | 8,229 | 2,271 | 3,264 | 8,544 | |
| Last Close Price | 73.64 | 27.44 | 40.37 | 7.62 | 16.68 | 71.11 | |
| PS Ratio | 39.65 | 23.37 | 754.92 | 14.67 | 35.22 | 1056.59 | |
| PB Ratio | - | -3.56 | -5.23 | -0.91 | -2.84 | 80.79 | |
| P/TBV Ratio | - | - | - | - | - | 150.52 | |
| EV/Sales Ratio | 43.54 | 30.02 | 884.51 | 29.25 | 46.81 | 1035.70 | |
| Debt / Equity Ratio | -0.97 | -1.19 | -1.30 | -1.38 | -1.99 | 4.60 | |
| Asset Turnover | 0.43 | 0.30 | 0.02 | 0.10 | 0.08 | 0.01 | |
| Quick Ratio | 3.52 | 4.44 | 3.04 | 4.03 | 6.34 | 6.35 | |
| Current Ratio | 3.88 | 4.67 | 3.32 | 4.52 | 6.58 | 6.72 | |
| Return on Equity (ROE) | - | - | - | - | - | -173.15% | |
| Return on Assets (ROA) | -43.48% | -47.83% | -64.08% | -35.80% | -41.75% | -44.42% | |
| Return on Capital (ROIC) | -161.27% | -104.60% | -85.54% | -43.72% | -48.94% | -50.63% | |
| Return on Capital Employed (ROCE) | -74.00% | -73.30% | -148.90% | -93.40% | -65.30% | -78.00% | |
| Earnings Yield | -5.62% | -10.33% | -9.16% | -42.24% | -22.91% | -5.15% | |
| FCF Yield | -4.13% | -10.06% | -7.53% | -37.25% | -20.82% | -4.67% | |
| Buyback Yield / Dilution | -4.48% | -14.30% | -10.39% | -2.16% | -22.34% | -12.27% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.